CytRx spins off non-core molecular chaperonesto fund oncology pipeline
17 May 2011
Nancy Faigen
Please Login to read the full article.
17 May 2011
Nancy Faigen
Nancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- RXi to spin off RNAi and focus on targeted cancer therapies
- Fibrocell acquires rights from UCLA; seeks a lead on adult mesenchymal stem cells from dermal skin cells
- Latest $110m incubator would add to recent early research investment in San Diego
- ASLAN gains global rights to Almirall's DHODH inhibitor for rheumatoid arthritis
COMMENT
Other Informa Comment
EVENTS
Today
Le Plaza Hotel, Brussels, Belgium
Today
Diplomat Hotel, Prague, Czech Republic
Today
Business Design Centre, London
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
